Skip to content
Monday 10 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
0.00%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Friday 22 March 2019 8:58 am  |  Updated:  Monday 03 June 2019 1:27 am

Smiths Group to spin off ailing medical division into separate listed company

By: James Warrington

Add as a preferred source on Google

British engineering firm Smiths Group will spin off its struggling medical business and list it separately on the London Stock Exchange, the company said today.

Smiths had unveiled plans for a demerger in November after a proposed sale of the healthcare unit to US firm ICU Medical fell through.

Read more: Smiths Group to spin off medical unit

But the company today said it expects to complete the process in the first half of 2020, subject to shareholder approval.

Chief executive Andy Reynolds Smith said: “Pursuing a demerger of Smiths Medical will lead to two stronger companies each focusing on accelerating the execution of their plans and maximising the opportunities in their respective markets.

“With sustained operational improvement and investment, both Smiths and Smiths Medical are well positioned to capitalise on their leadership positions and new products.”

Smiths, which manufactures a range of products from hospital equipment to airport security scanners, said it has begun the search for a chief executive of the new spin-off firm.

Russ Mould, investment director at AJ Bell, said the demerger was unsurprising, as the medical division did not fit well with the rest of the group.

“Separating business divisions can help the parent company be leaner and meaner, and for the orphaned operations to have a new life of their own with potentially more entrepreneurial decisions by management,” he said.

But he added: “As a standalone business, one cannot rule out Smiths Medical being subject to further takeover interest down the line.”

The move came as the company posted a two per cent rise in revenues to £1.6bn in the first half to the end of January.

Read more: Smiths Group buys Airbus supplier United Flexible

But pre-tax profit dropped 13 per cent to £174m, dragged down by poor trading in the medical division, which the firm said had been hit by regulatory and contract challenges.

Smiths maintained its forecast of underlying revenue growth of at least two per cent for the full-year. Shares in Smiths Group ticked up just over one per cent in early trading.

 

 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Company
  • Smiths Group

Trending Articles

  • Burnham facing calls to cut employment red tape as job seekers grow for 41 months

  • Government to inject millions into electric vehicle firms despite mandate backlash

  • Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

  • Stop burying us in swollen corporate reports, says audit watchdog boss

  • Hargreaves Lansdown orders staff back to office

More from Morning Wire

  • How to become a (successful) vintage watch collector

    Life&Style
    Collection of vintage watches displayed on a wooden table, showcasing diverse brands and styles for collectors
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
  • Watch out, Burnham

    watches
    Man in The Passage apron slicing food in a commercial kitchen, with a food allergens chart visible.
  • Almirall H1 2026 Results

    Business Wire
  • Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer

    Business Wire
  • Clinigen Appoints Greg Skalicky as Chief Executive Officer

    Business Wire
  • Cognita Reply Named an OpenAI Advanced Partner to Accelerate Enterprise Adoption of Frontier AI

    Business Wire
  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook